Das Klinikum Fulda ist ein Krankenhaus mit 1007 Betten bei einem Einzugsgebiet mit etwa 500.000 Menschen. Es ist nach der Anzahl der Betten das viertgrößte Krankenhaus in Hessen nach dem Universitätsklinikum Frankfurt, dem Klinikum Kassel und dem Universitätsklinikum Gießen und Marburg.

During the past decade, Klinikum Fulda conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Fulda" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "Terumo Europe N.V." with 2 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored, "Acandis GmbH" with 1 trials sponsored and "Acist Medical Systems" with 1 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Fulda" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "BARMER GEK Germany" with 1 trials as a collaborator and "Celerion" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Fulda" are "Lymphoma" (4 trials), "Coronary Artery Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Klinikum Fulda" in a lesser frequency.

Most popular intervention types in "Klinikum Fulda" are "Drug" (12 trials), "Biological" (5 trials), "Device" (5 trials), "Procedure" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "vincristine sulfate" (4 trials) and "radiation therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Fulda" are 26 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Fulda". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Klinikum Fulda, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Fulda, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Klinikum Fulda has several departments that took part in Clinical trials: "Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH" - 10 trials